About this Journal Submit a Manuscript Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 493670, 8 pages
http://dx.doi.org/10.1155/2012/493670
Research Article

Tau and Caspase 3 as Targets for Neuroprotection

The Adams Super Center for Brain Studies, The Lily and Avraham Gildor Chair for The Investigation of Growth Factors, The Elton Laboratory for Molecular Neuroendocrinology, and Department of Human Molecular Genetics and Biochemistry, Sagol School of Neuroscience, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel

Received 27 February 2012; Accepted 1 April 2012

Academic Editor: Hanna Rosenmann

Copyright © 2012 Anat Idan-Feldman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Yan Jouroukhin, Regina Ostritsky, and Illana Gozes, “D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy,” Journal of Molecular Neuroscience, vol. 48, no. 3, pp. 597–602, 2012. View at Publisher · View at Google Scholar
  • Saar Oz, Yanina Ivashko-Pachima, and Illana Gozes, “The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities,” PLoS ONE, vol. 7, no. 12, 2012. View at Publisher · View at Google Scholar
  • Illana Gozes, Yulie Schirer, Anat Idan-Feldman, Merav David, and Sharon Furman-Assaf, “NAP Alpha-Aminoisobutyric Acid (IsoNAP),” Journal of Molecular Neuroscience, 2013. View at Publisher · View at Google Scholar
  • Yan Jouroukhin, Regina Ostritsky, Yaniv Assaf, Galit Pelled, Eliezer Giladi, and Illana Gozes, “NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport,” Neurobiology of Disease, vol. 56, pp. 79–94, 2013. View at Publisher · View at Google Scholar
  • Da-Wei Dong, Yu-Sheng Zhang, Wan-Yong Yang, Run-Qi Wang-Qin, An-Ding Xu, and Yi-Wen Ruan, “Hyperphosphorylation of tau protein in the ipsilateral thalamus after focal cortical infarction in rats,” Brain Research, 2013. View at Publisher · View at Google Scholar
  • Iddo Magen, and Illana Gozes, “Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP),” Neuropeptides, 2013. View at Publisher · View at Google Scholar
  • Jing Sun, Yin-quan Fang, Hong Ren, Tao Chen, Jing-jing Guo, Jun Yan, Shu Song, Lu-yong Zhang, and Hong Liao, “WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra fol lowing permanent focal cerebral ischemia in rats,” Acta Pharmacologica Sinica, vol. 34, no. 1, pp. 119–128, 2013. View at Publisher · View at Google Scholar
  • Youssef Sari, Jason M. Weedman, and Maxwell Nkrumah-Abrokwah, “Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 Mouse,” Journal of Molecular Neuroscience, vol. 49, no. 1, pp. 150–156, 2013. View at Publisher · View at Google Scholar
  • Soraya Scuderi, Velia D’Agata, Agata Grazia D’Amico, Alessandro Castorina, Concetta Federico, Giuseppina Marrazzo, Filippo Drago, and Claudio Bucolo, “Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death,” Journal of Molecular Neuroscience, 2014. View at Publisher · View at Google Scholar